|
AKAP10 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62525548574877E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.43651757156249E-12 |
| Normal-vs-Stage2 |
2.85649999998139E-06 |
| Normal-vs-Stage3 |
5.55111512312578E-14 |
| Normal-vs-Stage4 |
1.57762691799235E-13 |
| Stage1-vs-Stage2 |
4.491400E-01 |
| Stage1-vs-Stage3 |
4.299800E-02 |
| Stage1-vs-Stage4 |
2.661400E-03 |
| Stage2-vs-Stage3 |
3.912000E-02 |
| Stage2-vs-Stage4 |
7.277000E-03 |
| Stage3-vs-Stage4 |
3.315000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.33066907387547E-16 |
| Normal-vs-AfricanAmerican |
1.167590E-04 |
| Normal-vs-Asian |
3.76069997365391E-09 |
| Caucasian-vs-AfricanAmerican |
2.680400E-01 |
| Caucasian-vs-Asian |
9.566200E-01 |
| AfricanAmerican-vs-Asian |
3.405600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.7715611723761E-15 |
| Normal-vs-Female |
1.70263803056514E-12 |
| Male-vs-Female |
1.848790E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.08919540053876E-11 |
| Normal-vs-Age(41-60Yrs) |
2.91333623891887E-12 |
| Normal-vs-Age(61-80Yrs) |
1.74982250911171E-12 |
| Normal-vs-Age(81-100Yrs) |
2.955400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.383400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.269600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.697600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.108600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.573200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.063200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.003700E-03 |
| Classical-VS-Follicular |
1.610620E-01 |
| Classical-VS-Other |
4.743600E-01 |
| Classical-VS-Normal |
1.63058455626697E-12 |
| Tall-VS-Follicular |
5.633300E-04 |
| Tall-VS-Other |
5.379200E-01 |
| Tall-VS-Normal |
4.51971793324901E-13 |
| Follicular-VS-Other |
3.139600E-01 |
| Follicular-VS-Normal |
1.62260000002856E-06 |
| Other-VS-Normal |
9.015900E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.06259445686874E-12 |
| Normal-vs-N1 |
1.11459996787744E-09 |
| N0-vs-N1 |
1.253810E-01 |
|
|
